INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

Search

Biotage AB

Atvērts

140.3 -1.06

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

140.1

Max

141.6

Galvenie mērījumi

By Trading Economics

Ienākumi

97M

158M

Pārdošana

92M

582M

P/E

Sektora vidējais

25.507

20.525

EPS

1.416

Dividenžu ienesīgums

1.82

Peļņas marža

27.148

Darbinieki

680

EBITDA

111M

222M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.82%

4.36%

Nākamie ieņēmumi

2025. g. 16. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-3.9B

7.2B

Iepriekšējā atvēršanas cena

141.36

Iepriekšējā slēgšanas cena

140.3

Biotage AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 22. apr. 06:50 UTC

Iegādes, apvienošanās, pārņemšana

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

2025. g. 22. apr. 06:04 UTC

Iegādes, apvienošanās, pārņemšana

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

2025. g. 22. apr. 06:03 UTC

Iegādes, apvienošanās, pārņemšana

KKR: Biotage Board Recommends Shareholders Accept Offer

2025. g. 22. apr. 06:02 UTC

Iegādes, apvienošanās, pārņemšana

KKR: Offer Values Biotage at SEK11.61B

2025. g. 22. apr. 06:02 UTC

Iegādes, apvienošanās, pārņemšana

KKR Makes SEK145 a Share Bid For Biotage

Salīdzinājums

Cenas izmaiņa

Biotage AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.